These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10494320

  • 1. [Arsenic trioxide, a new drug for the treatment of acute promyelocytic leukemia resistant to tretinoine].
    Haanen C, Vermes I.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1738-41. PubMed ID: 10494320
    [Abstract] [Full Text] [Related]

  • 2. Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
    Iland HJ, Collins M, Bradstock K, Supple SG, Catalano A, Hertzberg M, Browett P, Grigg A, Firkin F, Campbell LJ, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF, Australasian Leukaemia and Lymphoma Group.
    Lancet Haematol; 2015 Sep 21; 2(9):e357-66. PubMed ID: 26685769
    [Abstract] [Full Text] [Related]

  • 3. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, Khwaja A, Friis L, McMullin MF, Hunter A, Clark RE, Grimwade D, UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group.
    Lancet Oncol; 2015 Oct 21; 16(13):1295-305. PubMed ID: 26384238
    [Abstract] [Full Text] [Related]

  • 4. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z.
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun 29; 362(1482):959-71. PubMed ID: 17317642
    [Abstract] [Full Text] [Related]

  • 5. All-trans retinoic acid and arsenic trioxide resistance of acute promyelocytic leukemia with the variant STAT5B-RARA fusion gene.
    Strehl S, König M, Boztug H, Cooper BW, Suzukawa K, Zhang SJ, Chen HY, Attarbaschi A, Dworzak MN.
    Leukemia; 2013 Jul 29; 27(7):1606-10. PubMed ID: 23271512
    [No Abstract] [Full Text] [Related]

  • 6. Arsenic trioxide: new preparation. Acute promyelocytic leukaemia: encouraging results but persistent doubts.
    Prescrire Int; 2004 Aug 29; 13(72):135-7. PubMed ID: 15532137
    [Abstract] [Full Text] [Related]

  • 7. [Arsenic efficient in acute promyelocytic leukemia].
    Lehmann S, Paul C.
    Lakartidningen; 1999 Dec 15; 96(50):5626-8. PubMed ID: 10643228
    [Abstract] [Full Text] [Related]

  • 8. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J.
    Chin J Integr Med; 2007 Jun 15; 13(2):92-4. PubMed ID: 17609904
    [No Abstract] [Full Text] [Related]

  • 9. A single course of all-trans retinoic acid plus arsenic trioxide reached a long-term survival in a patient with newly diagnosed acute promyelocytic leukemia: a suggestion for reduction of treatment courses?
    Yan J, Chen X, Shao J.
    Eur J Haematol; 2013 Nov 15; 91(5):470-1. PubMed ID: 23869721
    [No Abstract] [Full Text] [Related]

  • 10. Arsenic: a new place?
    Vincent PC.
    Pathology; 1999 May 15; 31(2):81-2. PubMed ID: 10399159
    [No Abstract] [Full Text] [Related]

  • 11. Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia.
    Agis H, Weltermann A, Mitterbauer G, Thalhammer R, Edelhäuser M, Seewann HL, Valent P, Lechner K, Fonatsch C, Geissler K.
    Ann Hematol; 1999 Jul 15; 78(7):329-32. PubMed ID: 10466445
    [Abstract] [Full Text] [Related]

  • 12. Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
    Kennedy GA, Marlton P, Cobcroft R, Gill D.
    Br J Haematol; 2000 Dec 15; 111(4):1103-5. PubMed ID: 11167746
    [Abstract] [Full Text] [Related]

  • 13. Inhibition factors of arsenic trioxide therapeutic effects in patients with acute promyelocytic leukemia.
    Sui M, Zhang Z, Zhou J.
    Chin Med J (Engl); 2014 Dec 15; 127(19):3503-6. PubMed ID: 25269921
    [Abstract] [Full Text] [Related]

  • 14. Acute promyelocytic leukemia in childhood.
    Gregory J, Feusner J.
    Curr Oncol Rep; 2009 Nov 15; 11(6):439-45. PubMed ID: 19840521
    [Abstract] [Full Text] [Related]

  • 15. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H, Li K, Mei C, Wang H, Chen Z, Jin J.
    Ann Hematol; 2011 Dec 15; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract] [Full Text] [Related]

  • 16. [An analysis of the therapeutic effects and reactions in treating acute promyelocytic leukemia with intravenous arsenic trioxide or all-trans retinoic acid].
    Zhang X, Yang L, Qiao Z.
    Zhonghua Nei Ke Za Zhi; 1999 Feb 15; 38(2):113-5. PubMed ID: 11798639
    [Abstract] [Full Text] [Related]

  • 17. Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia.
    Mikoshiba M, Ohashi K, Takei N, Okuyama Y, Maeda Y, Hiruma K, Akiyama H, Fukuhara O, Takeshita A, Sakamaki H.
    Int J Hematol; 2002 Jan 15; 75(1):104-6. PubMed ID: 11843281
    [No Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide in the treatment of a patient with multiply recurrent, ATRA-resistant promyelocytic leukemia: a case report.
    Bergstrom SK, Gillan E, Quinn JJ, Altman AJ.
    J Pediatr Hematol Oncol; 1998 Jan 15; 20(6):545-7. PubMed ID: 9856675
    [Abstract] [Full Text] [Related]

  • 19. ATRA plus arsenic gets another "A" in APL.
    Park JH.
    Blood; 2012 Aug 23; 120(8):1535-6. PubMed ID: 22918418
    [Abstract] [Full Text] [Related]

  • 20. Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide.
    Sasaki M, Sugimoto K, Isobe Y, Oshimi K.
    Eur J Haematol; 2008 Aug 23; 81(2):160. PubMed ID: 18363868
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.